Quarterly highlights compared to third quarter 2019:
- Net revenue increased 19.9% to $518.0 million
- Comparable store sales growth of 15.7%; Adjusted Comparable
Store Sales Growth of 13.3%
- Net income of $41.0 million; Diluted EPS of $0.45
- Adjusted Operating Income of $54.7 million
- Adjusted Diluted EPS of $0.38
- Board authorizes $50 million share repurchase program
- Company makes $50 million Term Loan A
prepayment
National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision”
or the “Company”) today reported its financial results for the
third quarter ended October 2, 2021.
Given the impact of COVID-related store closures last year,
consistent with our second quarter earnings release, this release
includes a comparison of fiscal 2021 results to fiscal 2019
pre-COVID results, in addition to a condensed comparison to fiscal
2020. For a complete discussion of fiscal 2021 results as compared
to fiscal 2020, please see our Quarterly Report on Form 10-Q for
the quarter ended October 2, 2021 filed with the Securities and
Exchange Commission.
“We are pleased with our third quarter results, as sales
remained healthy with total sales up nearly 20% and comparable
store sales up over 13% on a 2-year basis against 2019,” stated
Reade Fahs, chief executive officer. “Additionally, despite Delta
variant concerns and a decline from an elevated average ticket last
year, we delivered a slight comp increase against 2020 on continued
growth in customer transactions. All credit goes to the dedicated
patient and customer care of the 2,000-plus optometrists and over
13,000 associates at National Vision who continue to successfully
navigate the many challenges this environment throws our way.”
Mr. Fahs continued, “During the quarter, we opened 14 stores and
continue to be excited about our long-term opportunities for
expansion and market share growth. Additionally, given our strong
cash flows, we made a voluntary $50 million prepayment under our
credit agreement earlier this week and today announced our board
approved a $50 million stock repurchase program. Looking ahead, as
sales trends and customer demand continue to normalize from record
levels during the COVID-19 pandemic, we believe we remain in a
position of strength to continue to deliver sustainable
growth.”
Adjusted Comparable Store Sales Growth, Adjusted Operating
Income, Adjusted EBITDA, Adjusted Diluted EPS, Adjusted Operating
Margin, Adjusted EBITDA Margin, and EBITDA are not measures
recognized under generally accepted accounting principles (“GAAP”).
Please see “Non-GAAP Financial Measures” and “Reconciliation of
Non-GAAP to GAAP Financial Measures” below for more
information.
Third Quarter 2021 Summary compared to Third Quarter
2019
- Net revenue increased 19.9% to $518.0 million compared to the
third quarter of 2019.
- Net revenue was positively impacted by 1.5% due to the timing
of unearned revenue.
- Comparable store sales growth was 15.7% and Adjusted Comparable
Store Sales Growth was 13.3%.
- During the third quarter of 2021, the Company opened 14 new
stores, closed one store, and ended the quarter with 1,262 stores.
Overall, store count grew 10.2% from September 28, 2019 to October
2, 2021.
- Costs applicable to revenue increased 10.7% to $226.5 million
compared to the third quarter of 2019. As a percentage of net
revenue, costs applicable to revenue decreased 360 basis points to
43.7% compared to the third quarter of 2019. This decrease as a
percentage of net revenue was primarily driven by lower growth in
optometrist-related costs, increased eyeglass mix and higher
eyeglass margin.
- SG&A increased 14.7% to $218.2 million compared to the
third quarter of 2019. As a percentage of net revenue, SG&A
decreased 200 basis points to 42.1% compared to the third quarter
of 2019. This decrease as a percentage of net revenue was primarily
driven by the leverage of corporate overhead and payroll expenses,
lower stock compensation expense, and lower performance-based
incentive compensation, partially offset by higher advertising
investment.
- Net income increased 3,339% to $41.0 million compared to the
third quarter of 2019. The net change in margin on unearned revenue
benefited Adjusted Diluted EPS by $0.04.
- Diluted earnings per share increased 2,976% to $0.45 compared
to the third quarter of 2019. Adjusted Diluted EPS increased 134%
to $0.38 compared to the third quarter of 2019.
- Adjusted Operating Income increased 110% to $54.7 million
compared to the third quarter of 2019. Adjusted Operating Margin
increased 460 basis points to 10.6% compared to the third quarter
of 2019. The net change in margin on unearned revenue benefited
Adjusted Operating Income by $5.1 million.
Third Quarter 2021 Summary compared to Third Quarter 2020
(condensed)
- Net revenue increased 6.7% to $518.0 million compared to the
third quarter of 2020.
- Net revenue was positively impacted by 1.3% due to the timing
of unearned revenue.
- Comparable store sales growth was 3.4% and Adjusted Comparable
Store Sales Growth was 0.2%.
- The Company opened 14 new stores, closed one store, and ended
the quarter with 1,262 stores. Overall, store count grew 5.1% from
September 26, 2020 to October 2, 2021.
- Net income increased 16.2% to $41.0 million compared to the
third quarter of 2020.
- Diluted earnings per share increased 6.7% to $0.45 compared to
the third quarter of 2020. Adjusted Diluted EPS decreased 28.5% to
$0.38 compared to the third quarter of 2020. The net change in
margin on unearned revenue benefited Adjusted Diluted EPS by
$0.04.
- Adjusted Operating Income decreased 19.2% to $54.7 million
compared to the third quarter of 2020. Adjusted Operating Margin
decreased 340 basis points to 10.6% compared to the third quarter
of 2020. The net change in margin on unearned revenue benefited
Adjusted Operating Income by $4.9 million.
Nine-Month Period 2021 Summary compared to Nine-Month Period
2019
- Net revenue increased 21.1% to $1.6 billion compared to the
same period of 2019.
- The impact from the timing of unearned revenue on net revenue
and profitability was immaterial.
- Comparable store sales growth was 15.5% and Adjusted Comparable
Store Sales Growth was 15.6%.
- The Company opened 59 new stores, closed two stores, and ended
the period with 1,262 stores.
- Costs applicable to revenue increased 11.0% to $687.1 million
compared to the same period of 2019. As a percentage of net
revenue, costs applicable to revenue decreased 390 basis points to
42.9% compared to the same period of 2019. This decrease as a
percentage of net revenue was primarily driven by higher eyeglass
margin, a higher mix of exam sales, and a lower growth in
optometrist-related costs.
- SG&A increased 19.3% to $676.0 million compared to the same
period of 2019. As a percentage of net revenue, SG&A decreased
60 basis points at 42.2% compared to the same period of 2019. The
decrease as a percentage of net revenue was primarily driven by the
leverage of corporate overhead and occupancy expenses, partially
offset by higher performance-based incentive compensation.
- Net income increased 323% to $122.0 million compared to the
same period of 2019.
- Diluted earnings per share increased 279% to $1.34 compared to
the same period of 2019. Adjusted Diluted EPS increased 106% to
$1.35 compared to the same period of 2019.
- Adjusted Operating Income increased 92.2% to $188.0 million
compared to the same period of 2019. Adjusted Operating Margin
increased 430 basis points to 11.7% compared to the same period of
2019.
Nine-Month Period 2021 Summary compared to Nine-Month Period
2020 (condensed)
- Net revenue increased 31.8% to $1.6 billion compared to the
same period of 2020.
- Net revenue was positively impacted by 1.2% due to the timing
of unearned revenue.
- Comparable store sales growth was 30.3% and Adjusted Comparable
Store Sales Growth was 31.1%.
- Net income increased 10,086% to $122.0 million compared to the
same period of 2020.
- Diluted earnings per share increased 9,168% to $1.34 compared
to the same period of 2020. Adjusted Diluted EPS increased 221% to
$1.35 compared to the same period of 2020. The net change in margin
on unearned revenue benefited Adjusted Diluted EPS by $0.10.
- Adjusted Operating Income increased 163% to $188.0
millioncompared to the same period of 2020. Adjusted Operating
Margin increased 580 basis points to 11.7% compared to the same
period of 2020. The net change in margin on unearned revenue
benefited Adjusted Operating Income by $11.0 million.
Balance Sheet and Cash Flow Highlights as of October 2,
2021
- The Company’s cash balance was $439.1 million as of October 2,
2021. The Company had no borrowings under its $300 million first
lien revolving credit facility, exclusive of letters of credit of
$6.4 million.
- Total debt was $620.0 million as of October 2, 2021, consisting
of outstanding first lien term loans, convertible senior notes
(“2025 Notes”) and finance lease obligations, net of unamortized
discounts.
- Cash flows from operating activities for the first nine months
of 2021 were $233.8 millioncompared to $203.7 million for the same
period of 2020 and $170.9 million for the same period of 2019.
- Capital expenditures for the first nine months of 2021 totaled
$58.9 millioncompared to $40.8 million for the same period of 2020
and $76.5 million for the same period of 2019.
Recent Developments
- Effective November 8, 2021, the Company's board of directors
authorized the Company to repurchase up to $50 million aggregate
amount of shares of the Company's Common Stock. Under the share
repurchase program, shares may be repurchased from time to time in
the Company's discretion through December 30, 2023 using a variety
of methods.
- On November 9, 2021, the Company voluntarily prepaid $50
million in existing Term A loans under its credit agreement.
Fiscal 2021 Outlook
The Company’s updated fiscal 2021 outlook reflects the currently
expected impacts related to COVID-19, however, the ultimate impacts
of COVID-19 on the Company’s financial outlook remain uncertain.
The outlook shown below assumes no material deterioration to the
Company’s current business operations as a result of COVID-19 and
its variants, governmental actions and regulations, including risks
stemming from vaccination and testing programs and mandates. Given
the uncertainties, dynamic nature, variants, and unknown duration
of the pandemic, the Company is continuing to evaluate the
potential impacts of COVID-19 on its business and additional
measures that may be taken in response thereto.
The Company is providing the following updated outlook for the
52 weeks ending January 1, 2022:
Updated Fiscal 2021
Outlook
Prior Fiscal 2021
Outlook
New Stores
~75
~75
Adjusted Comparable Store Sales
Growth1
21% - 22%
19% - 22%
Net Revenue
$2.04 - $2.06 billion
$2.01 - $2.06 billion
Adjusted Operating Income
$180 - $187 million
$180 - $187 million
Adjusted Diluted EPS2
$1.28 - $1.33
$1.28 - $1.33
Depreciation and Amortization3
~$98 million
~$98 million
Interest4
~$25 million
~$25 million
Tax Rate5
~26%
~26%
Capital Expenditures
$100 - $105 million
$100 - $105 million
1 - For the 52 weeks ending January 1,
2022 compared to the 52 weeks ended January 2, 2021
2 - Assumes 96.3 million shares, including
12.9 million shares for the convertible notes calculated using the
if-converted method
3 - Includes amortization of acquisition
intangibles of approximately $7.5 million for the 52 weeks ending
January 1, 2022
4 - Before the impact of gains or losses
related to hedge ineffectiveness and charges related to
amortization of debt discounts and deferred financing costs
5 - Excluding the impact of stock option
exercises
The fiscal 2021 outlook information provided above includes
Adjusted Operating Income and Adjusted Diluted EPS guidance, which
are non-GAAP financial measures management uses in measuring
performance. The Company is not able to reconcile these
forward-looking non-GAAP measures to GAAP without unreasonable
efforts because it is not possible to predict with a reasonable
degree of certainty the actual impact of certain items and
unanticipated events, including taxes and non-recurring items,
which would be included in GAAP results. The impact of such items
and unanticipated events could be potentially significant.
The fiscal 2021 outlook is forward-looking, subject to
significant business, economic, regulatory and competitive
uncertainties and contingencies, many of which are beyond the
control of the Company and its management, and based upon
assumptions with respect to future decisions, which are subject to
change. Actual results may vary and those variations may be
material. As such, the Company’s results may not fall within the
ranges contained in its fiscal 2021 outlook. The Company uses these
forward looking measures internally to assess and benchmark its
results and strategic plans.
Conference Call Details
A conference call to discuss the third quarter 2021 financial
results is scheduled for today, November 10, 2021, at 10:00 a.m.
Eastern Time. The U.S. toll free dial-in for the conference call is
866-754-6931 and the international dial-in is 636-812-6625. The
conference passcode is 8189528. A live audio webcast of the
conference call will be available on the “Investors” section of the
Company’s website www.nationalvision.com/investors, where
presentation materials will be posted prior to the conference
call.
A telephone replay will be available shortly after the broadcast
through Wednesday, November 17, 2021, by dialing 855-859-2056 from
the U.S. or 404-537-3406 from international locations, and entering
conference passcode 8189528. A replay of the audio webcast will
also be archived on the “Investors” section of the Company’s
website.
About National Vision Holdings, Inc.
National Vision Holdings, Inc. is the second largest optical
retail company in the United States (by sales) with more than 1,200
retail stores in 44 states and Puerto Rico. With a mission of
helping people by making quality eye care and eyewear more
affordable and accessible, the Company operates five retail brands:
America’s Best Contacts & Eyeglasses, Eyeglass World, Vision
Centers inside select Walmart stores, and Vista Opticals inside
select Fred Meyer stores and on select military bases, and several
e-commerce websites, offering a variety of products and services
for customers’ eye care needs.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended (the “Securities Act”) and Section 21E of the Securities
Exchange Act of 1934. These statements include, but are not limited
to, statements contained under “Fiscal 2021 Outlook” as well as
other statements related to our current beliefs and expectations
regarding the performance of our industry, the Company’s strategic
direction, market position, prospects and future results. You can
identify these forward-looking statements by the use of words such
as “outlook,” “guidance,” “believes,” “expects,” “potential,”
“continues,” “may,” “will,” “should,” “could,” “seeks,” “projects,”
“predicts,” “intends,” “plans,” “estimates,” “anticipates” or the
negative version of these words or other comparable words. Caution
should be taken not to place undue reliance on any forward-looking
statement as such statements speak only as of the date when made.
We undertake no obligation to publicly update or review any
forward-looking statement, whether as a result of new information,
future developments or otherwise, except as required by law.
Forward-looking statements are not guarantees and are subject to
various risks and uncertainties, which may cause actual results to
differ materially from those implied in forward-looking statements.
Such factors include, but are not limited to, the COVID-19 pandemic
and its resurgence and variants, and the impact of evolving
federal, state, and local governmental actions in response thereto,
including risks stemming from vaccination and testing programs and
mandates; customer behavior in response to the continuing pandemic
and its more recent outbreaks of variants; our ability to keep our
reopened stores open in a safe and cost-effective manner, or at
all, in light of the continuing COVID-19 pandemic and its
resurgence and variants; our ability to recruit and retain vision
care professionals for our stores in general and in light of the
pandemic; our ability to develop, maintain and extend relationships
with managed vision care companies, vision insurance providers and
other third-party payors; our ability to maintain the performance
of our host and legacy brands and our current operating
relationships with our host and legacy partners; our ability to
adhere to extensive state, local and federal vision care and
healthcare laws and regulations; our compliance with managed vision
care laws and regulations; our ability to maintain sufficient
levels of cash flow from our operations to execute or sustain our
growth strategy or obtain additional financing at satisfactory
terms or at all; the loss of, or disruption in the operations of,
one or more of our distribution centers and/or optical
laboratories, resulting in the inability to fulfill customer orders
and deliver our products in a timely manner; risks associated with
vendors from whom our products are sourced, including our
dependence on a limited number of suppliers; our ability to compete
successfully; our ability to effectively operate our information
technology systems and prevent interruption or security breach; our
growth strategy straining our existing resources and causing the
performance of our existing stores to suffer; the impact of wage
rate increases, inflation, cost increases and increases in raw
material prices and energy prices; our ability to successfully
implement our marketing, advertising and promotional efforts; risks
associated with leasing substantial amounts of space, including
future increases in occupancy costs; the impact of certain
technological advances, and the greater availability of, or
increased consumer preferences for, vision correction alternatives
to prescription eyeglasses or contact lenses, and future drug
development for the correction of vision-related problems; our
ability to retain our existing senior management team and attract
qualified new personnel; overall decline in the health of the
economy and other factors impacting consumer spending; our ability
to manage our inventory; seasonal fluctuations in our operating
results and inventory levels; our reliance on third-party coverage
and reimbursement, including government programs, for an increasing
portion of our revenues; risks associated with our e-commerce and
omni-channel business; product liability, product recall or
personal injury issues; our failure to comply with, or changes in,
laws, regulations, enforcement activities and other requirements;
the impact of any adverse litigation judgments or settlements
resulting from legal proceedings relating to our business
operations; risk of losses arising from our investments in
technological innovators in the optical retail industry; our
ability to adequately protect our intellectual property; our
significant amount of indebtedness and our ability to generate
sufficient cash flow to satisfy our debt obligations; a change in
interest rates as well as changes in benchmark rates and
uncertainty related to the foregoing; restrictions in our credit
agreement that limits our flexibility in operating our business;
potential dilution to existing stockholders upon the conversion of
our convertible notes; and risks related to owning our common
stock, including our ability to comply with requirements to design
and implement and maintain effective internal controls. Additional
information about these and other factors that could cause National
Vision’s results to differ materially from those described in the
forward-looking statements can be found in filings by National
Vision with the Securities and Exchange Commission (“SEC”),
including our latest Annual Report on Form 10-K, our Quarterly
Report on Form 10-Q filed on November 10, 2021, and subsequently
filed reports, which are accessible on the SEC’s website at
www.sec.gov. These factors should not be construed as exhaustive
and should be read in conjunction with the other cautionary
statements that are included in this release and in our filings
with the SEC.
Non-GAAP Financial Measures
To supplement the Company’s financial information presented in
accordance with GAAP and aid understanding of the Company’s
business performance, the Company uses certain non-GAAP financial
measures, namely “EBITDA,” “Adjusted Operating Income,” “Adjusted
Operating Margin,” “Adjusted EBITDA,” “Adjusted EBITDA Margin,”
“Adjusted Diluted EPS,” “Adjusted Comparable Stores Sales Growth,”
“Adjusted SG&A,” and “Adjusted SG&A Percent of Net
Revenue.” We believe EBITDA, Adjusted Operating Income, Adjusted
Operating Margin, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted
Diluted EPS, Adjusted SG&A and Adjusted SG&A Percent of Net
Revenue assist investors and analysts in comparing our operating
performance across reporting periods on a consistent basis by
excluding items that we do not believe are indicative of our core
operating performance. Management believes these non-GAAP financial
measures are useful to investors in highlighting trends in our
operating performance, while other measures can differ
significantly depending on long-term strategic decisions regarding
capital structure, the tax jurisdictions in which we operate and
capital investments. Management uses these non-GAAP financial
measures to supplement GAAP measures of performance in the
evaluation of the effectiveness of our business strategies, to make
budgeting decisions, to establish discretionary annual incentive
compensation and to compare our performance against that of other
peer companies using similar measures. Management supplements GAAP
results with non-GAAP financial measures to provide a more complete
understanding of the factors and trends affecting the business than
GAAP results alone.
To supplement the Company’s comparable store sales growth
presented in accordance with GAAP, the Company provides “Adjusted
Comparable Store Sales Growth,” which is a non-GAAP financial
measure we believe is useful because it provides timely and
accurate information relating to the two core metrics of retail
sales: number of transactions and value of transactions. Management
uses Adjusted Comparable Store Sales Growth as the basis for key
operating decisions, such as allocation of advertising to
particular markets and implementation of special marketing
programs. Accordingly, we believe that Adjusted Comparable Store
Sales Growth provides timely and accurate information relating to
the operational health and overall performance of each brand. We
also believe that, for the same reasons, investors find our
calculation of Adjusted Comparable Store Sales Growth to be
meaningful.
EBITDA: We define EBITDA as net income, plus interest
expense, income tax provision (benefit) and depreciation and
amortization.
Adjusted Operating Income: We define Adjusted Operating
Income as net income, plus interest expense and income tax
provision (benefit), further adjusted to exclude stock compensation
expense, loss on extinguishment of debt, asset impairment,
litigation settlement, secondary offering expenses, management
realignment expenses, long-term incentive plan expense,
amortization of acquisition intangibles, and other expenses.
Adjusted Operating Margin: We define Adjusted Operating
Margin as Adjusted Operating Income as a percentage of net
revenue.
Adjusted EBITDA: We define Adjusted EBITDA as net income,
plus interest expense, income tax provision (benefit) and
depreciation and amortization, further adjusted to exclude stock
compensation expense, loss on extinguishment of debt, asset
impairment, litigation settlement, secondary offering expenses,
management realignment expenses, long-term incentive plan expense,
and other expenses.
Adjusted EBITDA Margin: We define Adjusted EBITDA Margin
as Adjusted EBITDA as a percentage of net revenue.
Adjusted Diluted EPS: We define Adjusted Diluted EPS as
diluted earnings per share, adjusted for the per share impact of
stock compensation expense, loss on extinguishment of debt, asset
impairment, litigation settlement, secondary offering expenses,
management realignment expenses, long-term incentive plan expense,
amortization of acquisition intangibles, amortization of debt
discount and deferred financing costs of our term loan borrowings,
amortization of costs related to our 2025 Notes, losses (gains) on
change in fair value of derivatives, other expenses, and tax
benefit of stock option exercises, less the tax effect of these
adjustments. We adjust for amortization of costs related to the
2025 Notes only when adjustment for these costs is not required in
the calculation of diluted earnings per share according to U.S.
GAAP.
Adjusted SG&A: We define Adjusted SG&A as
SG&A, adjusted to exclude stock compensation expense, secondary
offering expenses, management realignment expenses, long-term
incentive plan expense, and other expenses.
Adjusted SG&A Percent of Net Revenue: We define
Adjusted SG&A Percent of Net Revenue as Adjusted SG&A as a
percentage of net revenue.
Adjusted Comparable Store Sales Growth: We measure
Adjusted Comparable Store Sales Growth as the increase or decrease
in sales recorded by the comparable store base in any reporting
period, compared to sales recorded by the comparable store base in
the prior reporting period, which we calculate as follows: (i)
sales are recorded on a cash basis (i.e., when the order is placed
and paid for or submitted to a managed care payor, compared to when
the order is delivered), utilizing cash basis point of sale
information from stores; (ii) stores are added to the calculation
during the 13th full fiscal month following the store’s opening;
(iii) closed stores are removed from the calculation for time
periods that are not comparable; (iv) sales from partial months of
operation are excluded when stores do not open or close on the
first day of the month; and (v) when applicable, we adjust for the
effect of the 53rd week. Quarterly, year-to-date and annual
adjusted comparable store sales are aggregated using only sales
from all whole months of operation included in both the current
reporting period and the prior reporting period. When a partial
month is excluded from the calculation, the corresponding month in
the subsequent period is also excluded from the calculation. There
may be variations in the way in which some of our competitors and
other retailers calculate comparable store sales. As a result, our
adjusted comparable store sales may not be comparable to similar
data made available by other retailers. We did not adjust our
calculation of Adjusted Comparable Store Sales Growth for the
temporary closure of our stores to the public in 2020 as a result
of the COVID-19 pandemic.
EBITDA, Adjusted Operating Income, Adjusted Operating Margin,
Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Diluted EPS,
Adjusted SG&A, Adjusted SG&A Percent of Net Revenue, and
Adjusted Comparable Store Sales Growth are not recognized terms
under GAAP and should not be considered as an alternative to net
income or the ratio of net income to net revenue as a measure of
financial performance, SG&A, the ratio of SG&A to net
revenue as a measure of financial performance, cash flows provided
by operating activities as a measure of liquidity, comparable store
sales growth as a measure of operating performance, or any other
performance measure derived in accordance with GAAP. Additionally,
these measures are not intended to be a measure of free cash flow
available for management’s discretionary use as they do not
consider certain cash requirements such as interest payments, tax
payments and debt service requirements. The presentations of these
measures have limitations as analytical tools and should not be
considered in isolation, or as a substitute for analysis of our
results as reported under GAAP. Because not all companies use
identical calculations, the presentations of these measures may not
be comparable to other similarly titled measures of other companies
and can differ significantly from company to company.
Please see “Reconciliation of Non-GAAP to GAAP Financial
Measures” below for reconciliations of non-GAAP financial measures
used in this release to their most directly comparable GAAP
financial measures.
National Vision Holdings, Inc.
and Subsidiaries
Condensed Consolidated Balance
Sheets
As of October 2, 2021 and
January 2, 2021
In Thousands, Except Par
Value
(Unaudited)
ASSETS
As of October 2, 2021
As of January 2, 2021
Current assets:
Cash and cash equivalents
$
439,117
$
373,903
Accounts receivable, net
54,080
57,989
Inventories
124,637
111,274
Prepaid expenses and other current
assets
28,553
23,484
Total current assets
646,387
566,650
Property and equipment, net
333,820
341,293
Other assets:
Goodwill
777,613
777,613
Trademarks and trade names
240,547
240,547
Other intangible assets, net
43,893
49,511
Right of use assets
344,341
340,141
Other assets
18,870
17,743
Total non-current assets
1,759,084
1,766,848
Total assets
$
2,405,471
$
2,333,498
LIABILITIES AND STOCKHOLDERS’
EQUITY
Current liabilities:
Accounts payable
$
76,124
$
64,861
Other payables and accrued expenses
98,749
110,309
Unearned revenue
35,328
32,657
Deferred revenue
68,763
58,899
Current maturities of long-term debt and
finance lease obligations
4,418
3,598
Current operating lease obligations
65,454
58,356
Total current liabilities
348,836
328,680
Long-term debt and finance lease
obligations, less current portion and debt discount
615,620
651,763
Non-current operating lease
obligations
325,786
327,371
Other non-current liabilities:
Deferred revenue
23,992
20,828
Other liabilities
13,586
17,415
Deferred income taxes, net
89,094
80,939
Total other non-current liabilities
126,672
119,182
Commitments and contingencies
Stockholders’ equity:
Common stock, $0.01 par value; 200,000
shares authorized; 83,667 and 82,183 shares issued as of October 2,
2021 and January 2, 2021, respectively; 82,693 and 81,239 shares
outstanding as of October 2, 2021 and January 2, 2021,
respectively
836
821
Additional paid-in capital
748,422
795,697
Accumulated other comprehensive loss
(2,840)
(4,400)
Retained earnings
272,176
142,880
Treasury stock, at cost; 974 and 944
shares as of October 2, 2021 and January 2, 2021, respectively
(30,037)
(28,496)
Total stockholders’ equity
988,557
906,502
Total liabilities and stockholders’
equity
$
2,405,471
$
2,333,498
National Vision Holdings, Inc.
and Subsidiaries
Condensed Consolidated
Statements of Operations and Comprehensive Income
For the Three and Nine Months
Ended October 2, 2021, September 26, 2020 and September 28,
2019
In Thousands, Except Earnings Per
Share
(Unaudited)
Three Months Ended
Nine Months Ended
October 2, 2021
September 26, 2020
September 28, 2019
October 2, 2021
September 26, 2020
September 28, 2019
Revenue:
Net product sales
$
425,594
$
403,336
$
355,789
$
1,326,867
$
1,005,884
$
1,096,482
Net sales of services and plans
92,411
82,017
76,113
274,807
209,180
226,086
Total net revenue
518,005
485,353
431,902
1,601,674
1,215,064
1,322,568
Costs applicable to revenue (exclusive
of depreciation and amortization):
Products
158,371
148,274
144,518
485,090
402,279
444,177
Services and plans
68,087
62,535
59,984
202,004
167,864
174,801
Total costs applicable to revenue
226,458
210,809
204,502
687,094
570,143
618,978
Operating expenses:
Selling, general and administrative
expenses
218,214
190,518
190,290
676,042
520,841
566,444
Depreciation and amortization
25,059
22,236
22,336
72,639
68,970
63,570
Asset impairment
—
7,150
3,516
1,478
20,916
7,387
Litigation settlement
—
—
—
—
4,395
—
Other expense (income), net
(2,437)
(154)
146
(2,567)
(312)
975
Total operating expenses
240,836
219,750
216,288
747,592
614,810
638,376
Income from operations
50,711
54,794
11,112
166,988
30,111
65,214
Interest expense, net
5,743
12,475
7,873
22,169
35,432
25,902
Debt issuance costs
—
—
—
92
136
—
Loss on extinguishment of debt
—
—
9,786
—
—
9,786
Earnings (loss) before income taxes
44,968
42,319
(6,547)
144,727
(5,457)
29,526
Income tax provision (benefit)
3,976
7,030
(7,739)
22,702
(6,655)
647
Net income
$
40,992
$
35,289
$
1,192
$
122,025
$
1,198
$
28,879
Earnings per share:
Basic
$
0.50
$
0.44
$
0.02
$
1.49
$
0.01
$
0.37
Diluted
$
0.45
$
0.42
$
0.01
$
1.34
$
0.01
$
0.35
Weighted average shares
outstanding:
Basic
82,290
80,676
78,474
81,729
80,376
78,387
Diluted
96,508
83,795
81,561
96,193
82,718
81,510
Comprehensive income (loss):
Net income
$
40,992
$
35,289
$
1,192
$
122,025
$
1,198
$
28,879
Unrealized gain (loss) on hedge
instruments
340
1,894
681
4,949
(2,853)
(2,837)
Tax provision (benefit) of unrealized gain
(loss) on hedge instruments
87
483
175
3,389
(723)
(727)
Comprehensive income (loss)
$
41,245
$
36,700
$
1,698
$
123,585
$
(932)
$
26,769
Note: The three and nine-months ended October 2, 2021 diluted
EPS is calculated using the if-converted method for the 2025 Notes
adding back $2.4 million and $7.1 million of interest expense
(after tax) related to the 2025 Notes, respectively, and assuming
conversion of the 2025 Notes at the beginning of 2021.
National Vision Holdings, Inc.
and Subsidiaries
Condensed Consolidated
Statements of Cash Flows
For the Nine Months Ended
October 2, 2021, September 26, 2020 and September 28, 2019
In Thousands
(Unaudited)
Nine Months Ended
October 2, 2021
September 26, 2020
September 28, 2019
Cash flows from operating
activities:
Net income
$
122,025
$
1,198
$
28,879
Adjustments to reconcile net income to net
cash provided by operating activities:
Depreciation and amortization
72,639
68,970
63,570
Amortization of debt discount and deferred
financing costs
3,140
7,248
1,071
Asset impairment
1,478
20,916
7,387
Deferred income tax expense (benefit)
23,585
(6,735)
651
Stock based compensation expense
13,866
8,335
10,840
Losses (gains) on change in fair value of
derivatives
(421)
4,596
—
Inventory adjustments
1,546
3,502
3,065
Loss on extinguishment of debt
—
—
9,786
Other
(242)
4,238
9,966
Changes in operating assets and
liabilities:
Accounts receivable
2,746
(5,685)
(4,988)
Inventories
(14,909)
12,354
1,063
Operating lease right of use assets and
lease liabilities
(456)
(1,258)
(1,146)
Other assets
(6,813)
1,044
9,748
Accounts payable
11,263
27,847
1,694
Deferred and unearned revenue
15,699
16,940
8,997
Other liabilities
(11,339)
40,206
20,355
Net cash provided by operating
activities
233,807
203,716
170,938
Cash flows from investing
activities:
Purchase of property and equipment
(58,920)
(40,837)
(76,472)
Other
2,475
323
564
Net cash used for investing activities
(56,445)
(40,514)
(75,908)
Cash flows from financing
activities:
Borrowings on long-term debt, net of
discounts
—
548,769
566,550
Repayments on long-term debt
(117,375)
(369,269)
(564,300)
Proceeds from exercise of stock
options
11,170
10,478
9,992
Purchase of treasury stock
(1,414)
(93)
(25,000)
Payments of debt issuance costs
(900)
(12,462)
(2,930)
Payments on finance lease obligations
(3,546)
(2,517)
(2,054)
Net cash provided by (used for) financing
activities
(112,065)
174,906
(17,742)
Net change in cash, cash equivalents and
restricted cash
65,297
338,108
77,288
Cash, cash equivalents and restricted
cash, beginning of year
375,159
40,307
17,998
Cash, cash equivalents and restricted
cash, end of period
$
440,456
$
378,415
$
95,286
Supplemental cash flow disclosure
information:
Cash paid for interest
$
17,316
$
19,508
$
25,182
Cash paid (received) for taxes
$
9,293
$
(693)
$
579
Capital expenditures accrued at the end of
the period
$
10,455
$
13,516
$
13,808
National Vision Holdings, Inc.
and Subsidiaries
Reconciliation of Non-GAAP to
GAAP Financial Measures
For the Three and Nine Months
Ended October 2, 2021, September 26, 2020 and September 28,
2019
In Thousands, Except Per Share
Information
(Unaudited)
Reconciliation of Adjusted Operating
Income to Net Income
Three Months Ended
Nine Months Ended
In thousands
October 2, 2021
September 26, 2020
September 28, 2019
October 2, 2021
September 26, 2020
September 28, 2019
Net income
$
40,992
$
35,289
$
1,192
$
122,025
$
1,198
$
28,879
Interest expense
5,743
12,475
7,873
22,169
35,432
25,902
Income tax provision (benefit)
3,976
7,030
(7,739)
22,702
(6,655)
647
Stock compensation expense (a)
3,665
2,890
6,123
13,866
8,335
10,840
Loss on extinguishment of debt (b)
—
—
9,786
—
—
9,786
Asset impairment (c)
—
7,150
3,516
1,478
20,916
7,387
Litigation settlement (d)
—
—
—
—
4,395
—
Secondary offering expenses (e)
—
—
401
—
—
406
Management realignment expenses (f)
—
—
—
—
—
2,155
Long-term incentive plan (g)
—
—
1,108
—
—
1,830
Amortization of acquisition intangibles
(h)
1,872
1,851
1,851
5,616
5,554
5,553
Other (k)
(1,512)
1,057
1,956
129
2,206
4,423
Adjusted Operating Income
$
54,736
$
67,742
$
26,067
$
187,985
$
71,381
$
97,808
Net income margin
7.9
%
7.3
%
0.3
%
7.6
%
0.1
%
2.2
%
Adjusted Operating Margin
10.6
%
14.0
%
6.0
%
11.7
%
5.9
%
7.4
%
Note: Percentages reflect line item as a
percentage of net revenue, adjusted for rounding
Reconciliation of EBITDA and Adjusted
EBITDA to Net Income
Three Months Ended
Nine Months Ended
In thousands
October 2, 2021
September 26, 2020
September 28, 2019
October 2, 2021
September 26, 2020
September 28, 2019
Net income
$
40,992
$
35,289
$
1,192
$
122,025
$
1,198
$
28,879
Interest expense
5,743
12,475
7,873
22,169
35,432
25,902
Income tax provision (benefit)
3,976
7,030
(7,739)
22,702
(6,655)
647
Depreciation and amortization
25,059
22,236
22,336
72,639
68,970
63,570
EBITDA
75,770
77,030
23,662
239,535
98,945
118,998
Stock compensation expense (a)
3,665
2,890
6,123
13,866
8,335
10,840
Loss of extinguishment of debt (b)
—
—
9,786
—
—
9,786
Asset impairment (c)
—
7,150
3,516
1,478
20,916
7,387
Litigation settlement (d)
—
—
—
—
4,395
—
Secondary offering expenses (e)
—
—
401
—
—
406
Management realignment expenses (f)
—
—
—
—
—
2,155
Long-term incentive plan (g)
—
—
1,108
—
—
1,830
Other (k)
(1,512)
1,057
1,956
129
2,206
4,423
Adjusted EBITDA
$
77,923
$
88,127
$
46,552
$
255,008
$
134,797
$
155,825
Net income margin
7.9
%
7.3
%
0.3
%
7.6
%
0.1
%
2.2
%
Adjusted EBITDA Margin
15.0
%
18.2
%
10.8
%
15.9
%
11.1
%
11.8
%
Note: Percentages reflect line item as a
percentage of net revenue, adjusted for rounding
Reconciliation of Adjusted Diluted EPS
to Diluted EPS
Three Months Ended
Nine Months Ended
In thousands, except per share amounts
October 2, 2021
September 26, 2020
September 28, 2019
October 2, 2021
September 26, 2020
September 28, 2019
Diluted EPS
$
0.45
$
0.42
$
0.01
$
1.34
$
0.01
$
0.35
Stock compensation expense (a)
0.04
0.03
0.08
0.14
0.10
0.13
Loss on extinguishment of debt (b)
—
—
0.12
—
—
0.12
Asset impairment (c)
—
0.09
0.04
0.02
0.25
0.09
Litigation settlement (d)
—
—
—
—
0.05
—
Secondary offering expenses (e)
—
—
0.00
—
—
0.00
Management realignment expenses (f)
—
—
—
—
—
0.03
Long-term incentive plan (g)
—
—
0.01
—
—
0.02
Amortization of acquisition intangibles
(h)
0.02
0.02
0.02
0.06
0.07
0.07
Amortization of debt discount and deferred
financing costs (i)
0.00
0.05
0.00
0.02
0.09
0.01
Losses (gains) on change in fair value of
derivatives (j)
(0.01)
0.00
—
0.00
0.06
—
Other (o)
(0.02)
0.01
0.02
(0.02)
0.03
0.05
Tax benefit of stock option exercises
(l)
(0.09)
(0.04)
(0.08)
(0.14)
(0.07)
(0.09)
Tax effect of total adjustments (m)
(0.01)
(0.05)
(0.08)
(0.06)
(0.16)
(0.14)
Adjusted Diluted EPS
$
0.38
$
0.54
$
0.16
$
1.35
$
0.42
$
0.66
Weighted average diluted shares
outstanding
96,508
83,795
81,561
96,193
82,718
81,510
Note: Some of the totals in the table
above do not foot due to rounding differences
Reconciliation of Adjusted SG&A and
Adjusted SG&A Percent of Net Revenue to SG&A
Three Months Ended
Nine Months Ended
In thousands
October 2, 2021
September 26, 2020
September 28, 2019
October 2, 2021
September 26, 2020
September 28, 2019
SG&A
$
218,214
$
190,518
$
190,290
$
676,042
$
520,841
$
566,444
Stock compensation expense (a)
3,665
2,890
6,123
13,866
8,335
10,840
Secondary offering expenses (e)
—
—
401
—
—
406
Management realignment expenses (f)
—
—
—
—
—
2,155
Long-term incentive plan (g)
—
—
1,108
—
—
1,830
Other (n)
843
1,057
1,727
2,484
2,206
3,187
Adjusted SG&A
$
213,706
$
186,571
$
180,931
$
659,692
$
510,300
$
548,026
SG&A Percent of Net Revenue
42.1
%
39.3
%
44.1
%
42.2
%
42.9
%
42.8
%
Adjusted SG&A Percent of Net
Revenue
41.3
%
38.4
%
41.9
%
41.2
%
42.0
%
41.4
%
Note: Percentages reflect line item as a
percentage of net revenue
(a) Non-cash charges related to stock-based compensation
programs, which vary from period to period depending on the timing
of awards and performance vesting conditions.
(b) Reflects write-off of deferred financing fees related
to the extinguishment of debt.
(c) Reflects write-off of property, equipment and lease
related assets on closed or underperforming stores.
(d) Expenses associated with settlement of significant
litigation.
(e) Expenses related to our secondary public offerings
for the three and nine months ended September 28, 2019.
(f) Expenses related to a non-recurring management
realignment described in the Current Report on Form 8-K filed with
the SEC on January 10, 2019.
(g) Expenses pursuant to a long-term incentive plan for
non-executive employees who were not participants in the management
equity plan for fiscal year 2019. This plan was effective in 2014
following the acquisition of the Company by affiliates of KKR &
Co. Inc. (the “KKR Acquisition”).
(h) Amortization of the increase in carrying values of
finite-lived intangible assets resulting from the application of
purchase accounting to the KKR Acquisition.
(i) Amortization of deferred financing costs and other
non-cash charges related to our long-term debt. We adjust for
amortization of costs related to the 2025 Notes only when
adjustment for these costs is not required in the calculation of
diluted earnings per share according to U.S. GAAP.
(j) Reflects losses (gains) recognized in interest
expense on change in fair value of de-designated hedges.
(k) Other adjustments include amounts that management
believes are not representative of our operating performance
(amounts in brackets represent reductions in Adjusted Operating
Income, Adjusted Diluted EPS and Adjusted EBITDA), including our
share of (gains) losses on equity method investments of $(2.4)
million and $0.2 million for the three months ended October 2, 2021
and September 28, 2019, respectively, and $(2.4) million and $1.2
million for the nine months ended October 2, 2021 and September 28,
2019, respectively; and other expenses and adjustments which are
primarily related to excess payroll taxes on stock option
exercises, executive severance and relocation.
(l) Tax benefit associated with accounting guidance
requiring excess tax benefits related to stock option exercises to
be recorded in earnings as discrete items in the reporting period
in which they occur.
(m) Represents the income tax effect of the total
adjustments at our combined statutory federal and state income tax
rates.
(n) Reflects otherexpenses in (k) above, except for our
share of (gains) losses on equity method investments of $(2.4)
million and $0.2 million for the three months ended October 2, 2021
and September 28, 2019, respectively, and $(2.4) million and $1.2
million for the nine months ended October 2, 2021 and September 28,
2019, respectively.
(o) Reflects otherexpenses in (k) above, including the
impact of stranded tax effect of $(2.1) million for the nine months
ended October 2, 2021 associated with our interest rate swaps that
matured in 2021.
Reconciliation of Adjusted Comparable
Store Sales Growth to Total Comparable Store Sales Growth
Comparable store sales
growth(a)
Third Quarter
Year to Date
2021 vs. 2019
2021 vs. 2020
2021 vs. 2019
2021 vs. 2020
2021 Outlook
Owned & Host segment
America’s Best
14.2
%
0.0
%
17.0
%
31.8
%
Eyeglass World
21.5
%
1.7
%
22.1
%
33.9
%
Military
(3.8)
%
(0.6)
%
(2.3)
%
22.6
%
Fred Meyer
(8.2)
%
(1.6)
%
(9.6)
%
21.2
%
Legacy segment
4.0
%
0.0
%
5.4
%
25.5
%
Total comparable store sales growth
15.7
%
3.4
%
15.5
%
30.3
%
20% - 21%
Adjusted Comparable Store Sales Growth
(b)
13.3
%
0.2
%
15.6
%
31.1
%
21% - 22%
(a) Total comparable store sales based on consolidated
net revenue excluding the impact of (i) Corporate/Other segment net
revenue, (ii) sales from stores opened less than 13 months, (iii)
stores closed in the periods presented, (iv) sales from partial
months of operation when stores do not open or close on the first
day of the month and (v) if applicable, the impact of a 53rd week
in a fiscal year. Brand-level comparable store sales growth is
calculated based on cash basis revenues consistent with what the
CODM reviews, and consistent with reportable segment revenues
presented in Note 10. “Segment Reporting” in our unaudited
condensed consolidated financial statements included in Part I.
Item 1. in our Quarterly Report on Form 10-Q, with the exception of
the Legacy segment, which is adjusted as noted in clause (b) (ii)
below.
(b) There are two differences between total comparable
store sales growth based on consolidated net revenue and Adjusted
Comparable Store Sales Growth: (i) Adjusted Comparable Store Sales
Growth includes the effect of deferred and unearned revenue as if
such revenues were earned at the point of sale, resulting in the
following changes from total comparable store sales growth based on
consolidated net revenue: a decrease of 2.2% for third quarter 2021
vs. 2019, a decrease of 3.0% for third quarter 2021 vs. 2020, an
increase of 0.1% for year to date 2021 vs. 2019 and an increase of
0.9% for year to date 2021 vs. 2020; and (ii) Adjusted Comparable
Store Sales Growth includes retail sales to the Legacy partner’s
customers (rather than the revenues recognized consistent with the
management & services agreement with the Legacy partner),
resulting in the following changes from total comparable store
sales growth based on consolidated net revenue: a decrease of 0.2%
for third quarter 2021 vs. 2019, a decrease of 0.2% for third
quarter 2021 vs. 2020 and a decrease of 0.1% for year to date 2021
vs 2020.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211110005596/en/
Investors:
National Vision Holdings, Inc. David Mann, CFA, Vice President
of Investor Relations (470) 448-2448
investor.relations@nationalvision.com
Media:
National Vision Holdings, Inc. Racheal Peters, Manager of
External Communications (470) 448-2303 media@nationalvision.com
National Vision (NASDAQ:EYE)
Historical Stock Chart
From May 2024 to Jun 2024
National Vision (NASDAQ:EYE)
Historical Stock Chart
From Jun 2023 to Jun 2024